Interestingly, reduced urinary kallikrein levels have been associated with the development of high blood pressure, which is one of the major risk factors in the development of cardiac hypertrophy, ischemic heart disease, and cardiac failure [28]. The gene discussed is KLK4; the disease is hypertensive disorder.